ClinicalTrials HQ

Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States

Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States

Recruiting · NCT05832229 · Registry updated 2026-09-28
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United StatesChemically-Induced Disorders, Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, alcohol-induced disorders, alcohol-related disorders, alcoholic liver cirrhosis, alcoholic liver disease, cirrhosis of liver, fatty liver disease, liver disorder, metabolic dysfunction-associated steatotic liver disease, substance-related disorderRecruitingPhase 22026-09-28NCT05832229

15 results · Page 1 of 1

13 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Cleveland ClinicClevelandUnited States2
Columbia University Iriving School of MedicineNew YorkUnited States2
Duke Liver CenterDurhamUnited States2
Keck Medical Center of USCLos AngelesUnited States21
LAC + USC Medical CenterLos AngelesUnited States2
Mayo ClinicRochesterUnited States22
New York Presbyterian/Weill CornellNew YorkUnited States2
UCSF Medical CenterSan FranciscoUnited States26
UCSF/Zuckerberg San Francisco General Hospital and Trauma CenterSan FranciscoUnited States2
University of California San Diego NAFLD Research CenterLa JollaUnited States2
University of Miami Health SystemMiamiUnited States2
University of MichiganAnn ArborUnited States538
Virginia Commonwealth UniversityRichmondUnited States156